Triple Negative Breast Cancer Epidemiology Forecast to 2032: Highlights Emerging Trends and Patient Pool Growth in Key Regions
30 janv. 2024 06h43 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry experts have...
HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
24 janv. 2024 10h35 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
HER2 Inhibitors Global Market Report 2023: Featuring F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan & Biocon
07 avr. 2023 07h03 HE
|
Research and Markets
Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
22 oct. 2021 04h53 HE
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...